All Professor Yoshinori Fujiyoshi articles

  • Close-up,Of,Coronavirus,Bacteria,Plastic,Model,,Micro,Virus,And,Covid-19
    News

    CeSPIACE: New peptide drug blocks COVID-19 variants

    2025-03-20T09:00:40Z

    Scientists have developed CeSPIACE, a peptide drug that offers broad protection against COVID-19 variants, including Omicron XBB.1.5. Find out how it targets a stable part of the virus’s spike protein, making it resistant to mutations.